UCB SA

PINK:UCBJF USA Biotechnology
Market Cap
$32.36 Billion
Market Cap Rank
#955 Global
#745 in USA
Share Price
$170.00
Change (1 day)
-2.47%
52-Week Range
$170.00 - $190.32
All Time High
$194.76
About

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company offers Cimzia for ankylosing spondylitis (AS), axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, polyarticular juvenile idiopathic arthritis, and rheumatoid arthritis; Vimpat, Keppra, … Read more

UCB SA (UCBJF) - Total Liabilities

Latest total liabilities as of December 2025: $7.29 Billion USD

Based on the latest financial reports, UCB SA (UCBJF) has total liabilities worth $7.29 Billion USD as of December 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

UCB SA - Total Liabilities Trend (2002–2025)

This chart illustrates how UCB SA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

UCB SA Competitors by Total Liabilities

The table below lists competitors of UCB SA ranked by their total liabilities.

Company Country Total Liabilities
Humana Inc
NYSE:HUM
USA $31.14 Billion
Halma PLC
PINK:HALMY
USA $1.35 Billion
Schindler Holding AG
PINK:SHLAF
USA $6.58 Billion
Banco Bradesco S.A.
SA:BBDC3
Brazil R$2.15 Trillion
Sandvik AB (publ)
PINK:SDVKF
USA $76.43 Billion
First Solar Inc
NASDAQ:FSLR
USA $3.78 Billion
Gree Electric Appliances Inc of Zhuhai
SHE:000651
China CN¥250.71 Billion
Great Wall Motor Company Ltd
PINK:GWLLY
USA $134.55 Billion

Liability Composition Analysis (2002–2025)

This chart breaks down UCB SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.38 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.67 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.40 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how UCB SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for UCB SA (2002–2025)

The table below shows the annual total liabilities of UCB SA from 2002 to 2025.

Year Total Liabilities Change
2025-12-31 $7.29 Billion -0.41%
2024-12-31 $7.32 Billion +11.49%
2023-12-31 $6.56 Billion -3.53%
2022-12-31 $6.80 Billion +16.83%
2021-12-31 $5.82 Billion -3.69%
2020-12-31 $6.05 Billion +48.50%
2019-12-31 $4.07 Billion -4.39%
2018-12-31 $4.26 Billion +1.87%
2017-12-31 $4.18 Billion -11.70%
2016-12-31 $4.74 Billion -12.48%
2015-12-31 $5.41 Billion +1.96%
2014-12-31 $5.31 Billion +0.02%
2013-12-31 $5.30 Billion +11.29%
2012-12-31 $4.77 Billion +9.46%
2011-12-31 $4.36 Billion -0.50%
2010-12-31 $4.38 Billion -6.93%
2009-12-31 $4.70 Billion -14.60%
2008-12-31 $5.51 Billion +4.08%
2007-12-31 $5.29 Billion -7.50%
2006-12-31 $5.72 Billion +147.83%
2005-12-31 $2.31 Billion -32.29%
2004-12-31 $3.41 Billion +160.76%
2003-12-31 $1.31 Billion +23.83%
2002-12-31 $1.06 Billion --